Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Med Microbiol ; 57(Pt 10): 1288-1292, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18809560

RESUMO

Coccidioidal pericarditis is a condition found in approximately 1-5% of patients infected by Coccidioides species. It is associated with widely diverse clinical symptoms. This paper reports a case of coccidioidal pericarditis diagnosed by an in-house Coccidioides posadasii antigen and confirmed with mycological and molecular methods. From February to September 2005, the patient suffered from fever, weight loss, a non-productive cough, thoracic pain and tachycardia. He received a positive diagnosis of coccidioidal pericarditis only in October 2005. The macromorphological examination of the culture showed a whitish felt-like colony, which became brownish with age. Preparations in lactophenol cotton blue stain showed hyaline septate hyphae with fragmentation and thin arthroconidia-like structures. Pericardial fluid and sera samples were positive for Coccidioides antibodies by immunodiffusion and ELISA with a C. posadasii in-house antigen preparation. The C. posadasii identification was confirmed by nested PCR of the antigen 2/proline-rich antigen (Ag2/PRA) encoding gene.


Assuntos
Antígenos de Fungos/imunologia , Coccidioides/isolamento & purificação , Coccidioidomicose/diagnóstico , Pericardite/microbiologia , Adulto , Antifúngicos/uso terapêutico , Antígenos de Fungos/genética , Coccidioides/genética , Coccidioides/imunologia , Coccidioidomicose/tratamento farmacológico , Coccidioidomicose/microbiologia , Fluconazol/uso terapêutico , Humanos , Imunodifusão , Masculino , Técnicas de Tipagem Micológica , Pericardite/tratamento farmacológico , Reação em Cadeia da Polimerase
2.
Trans R Soc Trop Med Hyg ; 106(8): 484-8, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22703696

RESUMO

This study contains a descriptive analysis of histoplasmosis in AIDS patients between 2006 and 2010 in the state of Ceará, Brazil. Additionally, the in vitro susceptibility of Histoplasma capsulatum isolates obtained during this period was assessed. We report 208 cases of patients with histoplasmosis and AIDS, describing the epidemiological, clinical, laboratory and therapeutic aspects. The in vitro antifungal susceptibility test was carried out by the microdilution method, according to Clinical and Laboratory Standards Institute, with H. capsulatum in the filamentous and yeast phases, against the antifungals amphotericin B, fluconazole, itraconazole, voriconazole and caspofungin. In 38.9% of the cases, histoplasmosis was the first indicator of AIDS and in 85.8% of the patients the CD4 cell count was lower than 100 cells/mm(3). The lactate dehydrogenase levels were high in all the patients evaluated, with impairment of hepatic and renal function and evolution to death in 42.3% of the cases. The in vitro susceptibility profile demonstrated there was no antifungal resistance among the isolates evaluated. There was a significant increase in the number of histoplasmosis cases in HIV-positive patients during the period surveyed in the state of Ceará, northeastern Brazil, but no antifungal resistance among the recovered isolates of H. capsulatum.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/microbiologia , Antifúngicos/uso terapêutico , Histoplasma/patogenicidade , Histoplasmose/diagnóstico , Histoplasmose/tratamento farmacológico , L-Lactato Desidrogenase/sangue , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Adulto , Anfotericina B/uso terapêutico , Brasil/epidemiologia , Contagem de Linfócito CD4 , Caspofungina , Equinocandinas/uso terapêutico , Feminino , Fluconazol/uso terapêutico , Histoplasma/isolamento & purificação , Histoplasmose/epidemiologia , Histoplasmose/microbiologia , Humanos , Itraconazol/uso terapêutico , Lipopeptídeos , Masculino , Testes de Sensibilidade Microbiana , Pirimidinas/uso terapêutico , Triazóis/uso terapêutico , Voriconazol
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa